Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[K-channel activators and cardioprotection]

G Specchia1, F Marsico, M L Laudisa

  • 1Dipartimento di Medicina Interna e Terapia Medica, Università degli Studi, Pavia.

Cardiologia (Rome, Italy)
|December 1, 1993
PubMed
Summary

Potassium channel openers show promise for treating hypertension and angina. These drugs offer cardioprotection against ischemia and reperfusion injury, potentially by mimicking preconditioning effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell-type-dependent expression of a somatic tri-allelic pattern at D18S51 and Penta D: The statistical interpretation of forensic evidence in sexual assault investigations.

Forensic science international. Genetics·2026
Same author

Real-World Efficacy and Safety of Gemtuzumab Ozogamycin (GO) and 3 + 7 regimen in fit newly diagnosed Acute Myeloid Leukemia (AML) patients. A Retrospective multicenter study of "Rete Ematologica Pugliese" (REP).

Leukemia research reports·2025
Same author

Treatment outcomes in sinonasal aspergillosis in dogs in the United Kingdom: 436 cases (2011-2021).

The Journal of small animal practice·2025
Same author

Choice of Frontline Tyrosine-Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A "Campus CML" Study.

European journal of haematology·2024
Same author

Diagnostic findings in sinonasal aspergillosis in dogs in the United Kingdom: 475 cases (2011-2021).

The Journal of small animal practice·2024
Same author

Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by 'Rete Ematologica Pugliese'.

Annals of hematology·2022

Area of Science:

  • Cardiovascular pharmacology
  • Ion channel modulation

Context:

  • K-channel openers are being investigated for their therapeutic potential.
  • Hypertension and angina management remain significant clinical challenges.

Purpose:

  • To explore the cardioprotective mechanisms of K-channel openers.
  • To evaluate the role of K-channel openers in mitigating ischemia-reperfusion injury.

Summary:

  • K-channel openers demonstrate beneficial hemodynamic effects, suggesting utility in hypertension and angina.
  • Experimental data indicate significant cardioprotection, reducing damage from myocardial ischemia and reperfusion.
  • Mechanisms may involve mimicking preconditioning, reducing calcium overload, and inhibiting oxidative damage.

Impact:

  • These findings support the development of K-channel openers as novel cardiovascular therapeutics.
  • Understanding these mechanisms can lead to improved treatments for ischemic heart conditions.

Related Experiment Videos